The store will not work correctly when cookies are disabled.
4-((1H-1,2,4-Triazol-1-yl)methyl)-2-(4-methoxyphenyl)-7Hpyrrolo[2,3-h]quinoline
ID: ALA2442761
PubChem CID: 136245971
Max Phase: Preclinical
Molecular Formula: C21H17N5O
Molecular Weight: 355.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2cc(Cn3cncn3)c3ccc4[nH]ccc4c3n2)cc1
Standard InChI: InChI=1S/C21H17N5O/c1-27-16-4-2-14(3-5-16)20-10-15(11-26-13-22-12-24-26)17-6-7-19-18(8-9-23-19)21(17)25-20/h2-10,12-13,23H,11H2,1H3
Standard InChI Key: ZOVMLGBTXVPKFU-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
3.0429 -4.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7619 -4.5356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4712 -3.2960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4721 -4.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1831 -4.5337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9023 -4.1232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9017 -3.2974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1858 -2.8861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0442 -3.2997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7581 -2.8862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5854 -2.0752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7689 -1.9942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4262 -2.7401 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6177 -2.8848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1848 -5.3587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9000 -5.7696 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9917 -6.5888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7990 -6.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2100 -6.0433 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6566 -5.4316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3304 -3.3021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0459 -2.8901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0470 -2.0628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3266 -1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6139 -2.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7612 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4758 -2.0620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 1 2 0
1 2 1 0
2 4 2 0
3 10 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 1 0
7 14 1 0
5 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 16 1 0
14 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 14 1 0
23 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 355.40 | Molecular Weight (Monoisotopic): 355.1433 | AlogP: 4.03 | #Rotatable Bonds: 4 |
Polar Surface Area: 68.62 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.19 | CX LogP: 3.57 | CX LogD: 3.57 |
Aromatic Rings: 5 | Heavy Atoms: 27 | QED Weighted: 0.53 | Np Likeness Score: -1.18 |
References
1. Ferlin MG, Carta D, Bortolozzi R, Ghodsi R, Chimento A, Pezzi V, Moro S, Hanke N, Hartmann RW, Basso G, Viola G.. (2013) Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors., 56 (19): [PMID:24025069] [10.1021/jm400377z] |